HIKMA PHARMS FDA Approval ANDA 208339

ANDA 208339

HIKMA PHARMS

FDA Drug Application

Application #208339

Documents

Letter2018-11-05

Application Sponsors

ANDA 208339HIKMA PHARMS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL250MG0ABIRATERONE ACETATEABIRATERONE ACETATE

FDA Submissions

UNKNOWN; ORIG1AP2018-10-31STANDARD
LABELING; LabelingSUPPL2AP2021-07-02STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null7

TE Codes

001PrescriptionAB

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208339
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ABIRATERONE ACETATE","activeIngredients":"ABIRATERONE ACETATE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/31\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/208339Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-10-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.